Skip to content
The Policy VaultThe Policy Vault

Provigil (modafinil)Highmark

Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)

Preferred products

  • generic armodafinil

Initial criteria

  • age ≥ 18 years
  • Diagnosis of obstructive sleep apnea/hypopnea syndrome (ICD-10: G47.33)
  • Member meets one (1) of the following (a. or b.): a. Currently receiving and compliant with positive airway pressure (PAP) OR b. Has experienced therapeutic failure, intolerance, or contraindication to PAP AND is currently using and compliant with a custom, titratable oral appliance
  • If request is for brand Provigil: therapeutic failure or intolerance to plan-preferred generic armodafinil AND generic modafinil
  • If request is for brand Nuvigil: therapeutic failure or intolerance to generic armodafinil AND generic modafinil

Reauthorization criteria

  • Member meets one (1) of the following (a. or b.): a. Currently receiving and compliant with positive airway pressure (PAP) OR b. Has experienced therapeutic failure, intolerance, or contraindication to PAP AND is currently using and compliant with a custom, titratable oral appliance
  • Member's symptoms of fatigue have improved

Approval duration

12 months